Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases

Modern Rheumatology

Volumn 13, Issue 2, 2003, Pages 129-134

  Hashimoto, Naoaki ^a   Iwasaki, Tsuyoshi ^a   Kitano, Masayasu ^a   Ogata, Atsushi ^a   Hamano, Teruaki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Hepatocyte growth factor (HGF); KL 6 Rheumatic diseases (RA); Vascular endothelial growth factor (VEGF); Vasculitis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; GLYCOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SCATTER FACTOR; THROMBOMODULIN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INTERSTITIAL LUNG DISEASE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAYNAUD PHENOMENON; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYSTEMIC SCLEROSIS;

EID: 0041671123     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.3109/s10165-002-0211-8     Document Type: Article

References (35)

1. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20.
2. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-9.
3. Grant DS, Kleinman HK, Goldberg ID, Bhargaba MM, Nickloff BJ, Kinsella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993;90:1937-41.
4. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41.
5. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995;129:1177-80.
6. Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 1998;139:1049-51.
7. Yoon CH, Min DJ, Cho ML, Park KS, Seo Y, Choi JJ, et al. Elevated vascular endothelial growth factor in patients with systemic sclerosis. Arhtritis Rheum 1999;42:A1179.
8. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, et al. A novel vascular modulator, hepatocyte growth factor (HGF), as a potent index of the severity of hypertension. Biochem Biophys Res Commun 1998;242:238-43.
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
13. Doria A, Ghirardello A, de Zambiasi P, Ruffanti A, Gambari PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992;19:259-64.
14. Cush JJ, Medsger TA Jr, Christy WC, Hebert DC, Cooperstein LA. Adult-onset Still's disease: clinical course and outcome. Arthritis Rheum 1987;30:186-94.
15. Clements P, Lachenbruch P, Seibold JR, White B, Weiner S, Martin RW, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TTS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
16. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
17. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-6.
18. Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995;22:1624-30.
19. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelia growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
20. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41.
21. Petrovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-4.
22. Cho CS, Cho ML, Min SY, Kim WU, Min DJ, Lee SS, et al. CD40 engagement of synovial fibroblast up-regulates vascular endothelial growth factor. J Immunol 2000;164:5055-61.
23. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1-beta. J Rheumatol 1997;24: 1253-9.
24. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, et al. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999;115:176-82.
25. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 1995;270:19761-6.
26. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, et al. Hepatocyte growth factor is a novel member of endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor, but not vascular endothelial growth factor. J Hypertens 1996;14:1067-72.
27. Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, et al. Elevated serum interleukin 6, interferon-γ, and tumor necrosis factor-α levels in patients with adult Still's disease. J Rheumatol 1998;25:396-8.
28. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
29. Kohono N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-16.
30. Sato S, Nagaoka T, Hasegawa M, Nishijima C, Takehara K. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis. Dermatology 2000;200:196-201.
31. Fukuya S, Oshima H, Kato K, Komatsu Y, Matsumura H, Ishii K, et al. KL-6 as a novel marker for activation of interstitial pneumonia in connective tissue diseases. Rheumatol Int 2000;19:223-5.
32. Maeda J, Ueki N, Hada T, Higashino K. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med 1995;152:1587-91.
33. Ohmichi H, Matsumoto K, Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotropic role in lung regeneration. Am J Physiol 1996;270:L1031-9.
34. Mason RJ, Leslie CC, McCormick-Shannon K, Deterding RR, Nakamura T, Rubin JS, et al. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol 1994;11:561-7.
35. Monacci WT, Merrill MJ, Oldfield EH. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993;264:C995-1002.